Literature DB >> 3280909

Metronidazole.

B E Scully1.   

Abstract

Metronidazole is a highly effective therapy for anaerobic infections and a variety of protozoal and parasitic diseases. Its pharmacokinetics, toxicities, and unique mode of action are reviewed in detail. Indications for use and respective dosages are suggested.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3280909     DOI： 10.1016/s0025-7125(16)30761-1

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN： 0025-7125            Impact factor:   5.456


  5 in total

1.  Drug susceptibility testing of anaerobic protozoa.

Authors:  J A Upcroft; P Upcroft
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  In vitro selection of resistant Helicobacter pylori.

Authors:  C E Haas; D E Nix; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1990-09       Impact factor: 5.191

Review 3.  Tackling antimicrobial stewardship through synergy and antimicrobial peptides.

Authors:  Jenna M Greve; James A Cowan
Journal:  RSC Med Chem       Date:  2022-04-04

4.  Effects of antibiotics on bacterial species composition and metabolic activities in chemostats containing defined populations of human gut microorganisms.

Authors:  Dorothy F Newton; Sandra Macfarlane; George T Macfarlane
Journal:  Antimicrob Agents Chemother       Date:  2013-02-12       Impact factor: 5.191

5.  In vitro activities of metronidazole and its hydroxy metabolite against Bacteroides spp.

Authors:  S L Pendland; S C Piscitelli; P C Schreckenberger; L H Danziger
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.